Document is current
Any future updates will be listed below
-
Authors
Vishwanath, Sneha https://orcid.org/0000-0001-9960-547X
Carnell, George William https://orcid.org/0000-0001-8875-0989
Ferrari, Matteo
Asbach, Benedikt https://orcid.org/0000-0003-1056-8591
Billmeier, Martina
George, Charlotte https://orcid.org/0000-0002-6585-3288
Sans, Maria Suau
Nadesalingam, Angalee
Huang, Chloe Qingzhou https://orcid.org/0009-0009-1503-1030
Paloniemi, Minna https://orcid.org/0000-0001-9288-4461
Stewart, Hazel https://orcid.org/0000-0003-1438-1089
Chan, Andrew
Wells, David Arthur https://orcid.org/0000-0002-4531-5968
Neckermann, Patrick
Peterhoff, David
Einhauser, Sebastian
Cantoni, Diego
Neto, Martin Mayora https://orcid.org/0000-0002-5331-5554
Jordan, Ingo https://orcid.org/0000-0003-2711-7252
Sandig, Volker
Tonks, Paul
Temperton, Nigel https://orcid.org/0000-0002-7978-3815
Frost, Simon
Sohr, Katharina
Ballesteros, Maria Teresa Lluesma
Arbabi, Farzad
Geiger, Johannes
Dohmen, Christian
Plank, Christian
Kinsley, Rebecca
Wagner, Ralf
Heeney, Jonathan Luke https://orcid.org/0000-0003-2702-1621
- License Information
-
More Information
Article History
Received: 5 November 2021
Accepted: 23 August 2023
First Online: 25 September 2023
Competing interests
: M.F., D.A.W., S.F., R.K., R.W. and J.L.H. are employees or shareholders of DIOSynVax Ltd. S.F. is an employee of Microsoft. I.J. and V.S. are employees of ProBioGenAG. K.S., M.T.L.B., F.A., J.G., C.D. and C.P. are employees of Ethris GmbH. The sequences of the antigens have been patented under UK Patent Application No. 2303150.3, Coronavirus Vaccines. All other authors have no competing interests.
